Microneedling-assisted photodynamic therapy for the treatment of actinic keratosis: Results from a systematic review and meta-analysis - 09/01/20
Doi : 10.1016/j.jaad.2019.09.037
Theresa Steeb, MPH a, Anne-Charlotte Niesert, MD a, Lars E. French, MD a, Carola Berking, MD a, b, ⁎ 
, Markus V. Heppt, MD, MSc, MHBA a, b
, Markus V. Heppt, MD, MSc, MHBA a, b a Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilian University (LMU) Munich, Germany
b Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
∗Correspondence to: Carola Berking, MD, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, GermanyDepartment of DermatologyUniversity Hospital ErlangenFriedrich-Alexander-University Erlangen-Nürnberg (FAU)Ulmenweg 18Erlangen91054Germany
| Funding sources: None. |
|
| Conflicts of interest: Dr Berking has been member of advisory boards for Almirall Hermal, Biofrontera, Galderma, ISDIN, and Leo Pharma; has received speaker's honoraria from Almirall Hermal, Galderma, and Leo Pharma; and has received funding for clinical research from Leo Pharma. Ms Steeb and Drs Niesert, French, and Heppt have no conflicts of interest to declare. |
|
| IRB approval status: Not applicable. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 515-519 - février 2020 Retour au numéro
Article précédent
- Impact of dermatology and teledermatology consultations for patients admitted with cellulitis: A pilot study
- Preeta Gupta, Starling Tolliver, Myron Zhang, Eric Schumacher, Benjamin H. Kaffenberger
- Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)
- Mark G. Lebwohl, Craig L. Leonardi, Nehal N. Mehta, Alice B. Gottlieb, Alan M. Mendelsohn, Jeff Parno, Stephen J. Rozzo, Alan Menter
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?